187 related articles for article (PubMed ID: 3526792)
1. [A trial of polychemotherapy of leprosy in the Dakar region. Initial observations on the acceptability of the protocols used].
Millan J; Bodian M; Naudin JC; Diouf B; Boucher P; Ndoye B; Grosset J
Acta Leprol; 1986; 4(1):19-35. PubMed ID: 3526792
[TBL] [Abstract][Full Text] [Related]
2. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
3. [Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences].
Millan J; Roux G; Loko S; Naudin JC; Boucher P; Bodian M; Camara M; Moreira-Diop T; Grosset J
Acta Leprol; 1986; 4(4):427-44. PubMed ID: 3296613
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
5. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
6. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
[TBL] [Abstract][Full Text] [Related]
7. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of multidrug therapy (MDT) in Hansen's disease in an urban population--Curupaiti State Hospital, Rio de Janeiro, Brazil.
Andrade VL; Marques AB; da Cunha LH; Avelleira JR
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):435-40. PubMed ID: 3655459
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of MDT in multibacillary leprosy.
Jesudasan K; Vijayakumaran P; Manimozhi N; Rao PS; Samuel P
Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):128-32. PubMed ID: 8690970
[TBL] [Abstract][Full Text] [Related]
10. Combined regimens of one year duration in the treatment of multibacillary leprosy--II. Combined regimens with rifampicin administered during 6 months.
Pattyn SR; Groenen G; Janssens L; Deverchin J; Ghys P
Lepr Rev; 1989 Jun; 60(2):118-23. PubMed ID: 2671560
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota BR; Shrestha K; Pandey B; Walker SL
Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
[TBL] [Abstract][Full Text] [Related]
12. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens.
Fajardo TT; Villahermosa L; Pardillo FE; Abalos RM; Burgos J; Dela Cruz E; Gelber RH
Am J Trop Med Hyg; 2009 Aug; 81(2):330-4. PubMed ID: 19635893
[TBL] [Abstract][Full Text] [Related]
13. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS
Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
[TBL] [Abstract][Full Text] [Related]
14. Fixed duration MDT in paucibacillary leprosy.
Mathai R; George S; Jacob M
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
[TBL] [Abstract][Full Text] [Related]
15. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
[TBL] [Abstract][Full Text] [Related]
16. Multidrug therapy (MDT) and leprosy control.
Noordeen SK
Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
[No Abstract] [Full Text] [Related]
17. [Acceptability, compliance and tolerance of daily polychemotherapy by leprosy patients in Guadeloupe].
Cartel JL; Gallais JJ; Grosset JH
Acta Leprol; 1985; 3(4):339-55. PubMed ID: 3913270
[TBL] [Abstract][Full Text] [Related]
18. Experience with multidrug therapy in paucibacillary leprosy.
Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
[TBL] [Abstract][Full Text] [Related]
19. Short term combination therapy for paucibacillary leprosy--histological evaluation & follow-up study.
Kumar B; Kaur S; Kaur I
Indian J Lepr; 1987; 59(1):54-62. PubMed ID: 3302061
[TBL] [Abstract][Full Text] [Related]
20. Implementation of tests for monitoring drug compliance of leprosy out-patients under multi-drug therapy.
Balakrishnan S; Kumar A; Rao BR; Patro TP
Indian J Lepr; 1986; 58(4):555-9. PubMed ID: 3572097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]